Literature DB >> 29920496

Stress Aggravates High-Fat-Diet-Induced Insulin Resistance via a Mechanism That Involves the Amygdala and Is Associated with Changes in Neuroplasticity.

Sheng-Feng Tsai1, Hung-Tsung Wu2, Pei-Chun Chen1,3, Yun-Wen Chen1,4, Megan Yu5, Shun-Fen Tzeng1,6, Pei-Hsuan Wu7, Po-See Chen7,8, Yu-Min Kuo1,9.   

Abstract

BACKGROUND: The notion that exposure to chronic stress predisposes individuals to developing type 2 diabetes (T2D) has gained much attention in recent decades. Long-term stress induces neuroadaptation in the amygdala and increases corticosterone levels. Corticosterone, the major stress hormone in rodents, induces insulin resistance and obesity in mice. However, little is known about whether the stress-induced amygdalar neuroadaptation could promote the risk of T2D.
METHODS: We used an 11-week high-fat diet (HFD) feeding paradigm to induce insulin dysfunction in mice, followed by implementation of a 10-day social defeat (SD) stress protocol.
RESULTS: Mice receiving SD at the beginning of the HFD feeding aggravated HFD-induced insulin resistance and white adipose tissue expansion. HFD mice had higher levels of plasma corticosterone, which was not affected by the SD. The SD stress upregulated the expression of TrkB and synaptotagmin-4 in the amygdala of HFD mice. Bilateral lesions of the central amygdalae before SD stress inhibited the stress-induced aggravating effect without affecting the HFD-induced elevation of plasma corticosterone.
CONCLUSIONS: Stress aggravates HFD-induced insulin resistance and neuroadaptation in the amygdala. The HFD-induced insulin resistance is amygdala-dependent. Understanding the role of stress-induced amygdalar adaptation in the development of T2D could inform therapies aimed at reducing chronic stressors to decrease the risk for T2D.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Amygdalar lesion; Diabetes; Glucose homeostasis; Social defeat

Mesh:

Year:  2018        PMID: 29920496     DOI: 10.1159/000491018

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  6 in total

1.  High-fat diet induces depression-like phenotype via astrocyte-mediated hyperactivation of ventral hippocampal glutamatergic afferents to the nucleus accumbens.

Authors:  Sheng-Feng Tsai; Pei-Ling Hsu; Yun-Wen Chen; Mohammad Shahadat Hossain; Pei-Chun Chen; Shun-Fen Tzeng; Po-See Chen; Yu-Min Kuo
Journal:  Mol Psychiatry       Date:  2022-09-30       Impact factor: 13.437

2.  Predicting resectability of primary tumor and mesenteric lymph-node masses in patients with small-intestine neuroendocrine tumors.

Authors:  Emilio Bertani; Fabio Zugni; Davide Radice; Francesca Spada; Guido Bonomo; Uberto Fumagalli Romario; Nicola Fazio; Luigi Funicelli
Journal:  Updates Surg       Date:  2022-02-27

3.  Disrupted hypothalamic CRH neuron responsiveness contributes to diet-induced obesity.

Authors:  Canjun Zhu; Yuanzhong Xu; Zhiying Jiang; Jin Bin Tian; Ryan M Cassidy; Zhao-Lin Cai; Gang Shu; Yong Xu; Mingshan Xue; Benjamin R Arenkiel; Qingyan Jiang; Qingchun Tong
Journal:  EMBO Rep       Date:  2020-05-27       Impact factor: 8.807

4.  PI3K/Akt pathway expression in children with different obesity degrees and its relationship with glucolipid metabolism and insulin resistance.

Authors:  Xiaoyan Su; Deming Gu; Li Xu; Zhenming Liang; Xuan Luo; Pu Yang; Jing Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 5.  The hypothalamus for whole-body physiology: from metabolism to aging.

Authors:  Tiemin Liu; Yong Xu; Chun-Xia Yi; Qingchun Tong; Dongsheng Cai
Journal:  Protein Cell       Date:  2021-04-07       Impact factor: 15.328

6.  Metformin Treatment Attenuates Brain Inflammation and Rescues PACAP/VIP Neuropeptide Alterations in Mice Fed a High-Fat Diet.

Authors:  Mawj Mandwie; Jocelyn Karunia; Aram Niaz; Kevin A Keay; Giuseppe Musumeci; Claire Rennie; Kristine McGrath; Ghaith Al-Badri; Alessandro Castorina
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.